维普期刊资源整合服务平台（V6.5）

22篇 您的检索式：作者名="GEDALY R"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Distal splenorenal shunt: role, indications, and utility in the era of liver transplan- tation显示文摘	Jenkins RL Gedaly R Pomposelli JJ	1999	Arch Surg1999，134，：	1
2	Targeting the Wnt/βcatenin signaling pathway in liver cancer stem cells and hepatocellular carcinoma cell lines with FH535显示文摘	Gedaly R Galuppo R Daily MF	2014	PLoS One2014，9，99：	1
3	PI-103 and sorafenib inhibit hepatocellular carcinoma cell proliferation by blocking Ras/Raf/MAPK and PI3K/AKT/mTOR pathways显示文摘	Gedaly R Angulo P Hundley J	2010	Anticancer Res2010，30，12：	1
4	PI - 103 and so- rafenib inhibit hepatocellular carcinoma cell proliferation by bloc- king Ras/Raf/MAPK and PI3 K/AKT/mTOR pathways显示文摘	GEDALY R ANGULO P HUNDLEY J	2010	Anti- cancer Res2010，30，12：	1
5	Cavemous Hemangioma of the Liver Anatomic Resection vs Enucleation 显示文摘	Gedaly R Pomposclli J J Pomfret E A W	1999	Arch Surg1999，134，：	1
6	PKI-587 and sorafenib tar geting PI3K/AKT/mTOR and Ras/Raf/MAPK pathways syn- erqistically inhibit HCC cell proliferation显示文摘	Gedaly R Angulo P Hundley J	2012	176(2) : 542- 5482012，176，2：	1
7	Cavernous hemangioma of the liver: anatomic resection vs enucleation 显示文摘	Gedaly R Pomposelli JJ Pomfret EA	1999	Arch Surg1999，134，4：	1
8	Liver trans- plantation for the treatment of liver metastases from neuroendocrine tumors: an analysis of UNOS database 显示文摘	Gedaly R Daily M F Davenport D	2011	Arch Surg2011，146，：	1
9	PI - 103 and sorafenib inhibit hepatocellular carcinoma cell proliferation by blocking Ras/Raf/MAPK and PI3K/AKT/mTOR pathways 显示文摘	Gedaly R Angulo P Hundley J	2010	Anticaneer Res2010，30，12：	1
10	P1-103 and sorafenib inhibit hepatocellular carcinoma cell proliferation by blocking Ras/Raf/MAPK and PI 3 K/AKT/mTOR pathways显示文摘	GEDALY R ANGULO P HUNDLEY J	2010	Anticancer Res2010，30，12：	1
11	Cavernous hemangioma of the liver anatomic resection vs enucleation 显示文摘	Gedaly R PomposelliJJ Pomfret EA	1999	Arch Surg1999，134，4：	1
12	Targeting the Wnt/β-Catenin Signaling Pathway in Liver Cancer Stem Cells and Hepatocellular Carcinoma CellLines with FH535显示文摘	Gedaly R Galuppo R Daily MF	2014	PLoS One2014，9，99：	1
13	PI-103 and sorafenib inhibit hepatocellular carcinoma cell proliferation by blocking Ras/Raf/MAPK and PI3K/Akt/mTOR pathways显示文摘	Gedaly R Angulo P Hundley J	2010	Anticancer Res2010，30，12：	1
14	Cavernous hemangioma of the liver: anatomic resection vs enucleation 显示文摘	GEDALY R POMPOSELLI JJ POMFRET FA	1999	Arch Surg1999，134，4：	1
15	Targeting the Wnt/beta- catenin signaling pathway in liver cancer stem cells and hepatocel- lular carcinoma cell lines with FH535显示文摘	Gedaly R Galuppo R Daily MF	2014	PIoS One2014，9，99：	1
16	Targeting the Wnt/β-catenin signaling pathway in liver cancer stem cells and hepa-tocellular carcinoma cell lines with FH535显示文摘	Gedaly R Galuppo R Daily MF	2014	PLoS One2014，9，99：	1
17	Cavernous hemangioma of the liver:anatomic resection vs enucleation显示文摘	Pomposelli JJ Pomfret EA	1999	Arch Surg1999，134，4：	1
18	Use of percutaneous liver biopsies in marginal liver donors 显示文摘	Ganz S Abdullah K Gedaly R	2001	Transplant Proc2001，33，12：	1
19	Role of surgery and trans-plantation in the Ireatment ol' hepatic metastases fram neuroemlo- trine tumor显示文摘	Alagusundaramoorthy SS Gedaly R	2014	World J Gastroenterol2014，20，14：	1
20	PKI-587 and so- rafenib targeting PI3K/AKT/mTOR and Ras/Raf/MAPK pathways synergistically inhibit HCC cell proliferation显示文摘	Gedaly R Angulo P Hundley J	2012	J Surg Res2012，176，2：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示